Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Business Gazette.
Press releases published on July 25, 2025
Global Herpes Simplex Virus Treatment Market Set for Steady Growth Through 2031
EIN Presswire
·
July 25, 2025
PORTLAND, OR, UNITED STATES, July 25, 2025 /EINPresswire.com/ -- The global herpes simplex virus (HSV) treatment market, valued at approximately $1.72 billion in 2021, is anticipated to reach $2.13 billion by 2031, registering a compound annual growth …
Portage Biotech Reports Results for Fiscal Year Ended March 31, 2025
GlobeNewswire
·
July 25, 2025
DOVER, Del., July 25, 2025 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (“Portage” or the “Company”) (NASDAQ: PRTG), a clinical-stage immuno-oncology company formed under the laws of the British Virgin Islands, with a portfolio of novel multi-targeted …
Arbor Realty Trust Schedules Second Quarter 2025 Earnings Conference Call
GlobeNewswire
·
July 25, 2025
UNIONDALE, N.Y., July 25, 2025 (GLOBE NEWSWIRE) -- Arbor Realty Trust, Inc. (NYSE: ABR), today announced that it is scheduled to release second quarter 2025 financial results before the market opens on Friday, August 1, 2025. The Company will host a …
IRADIMED CORPORATION to Hold Second Quarter of 2025 Financial Results Conference Call on August 1, 2025
GlobeNewswire
·
July 25, 2025
ORLANDO, Fla., July 25, 2025 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2025 second quarter financial results before the market opens on Friday, August 1, 2025. Iradimed management will host a …
Celcuity to Announce Topline Results for the PIK3CA Wild-Type Cohort from Phase 3 VIKTORIA-1 Trial in HR+/HER2- Advanced Breast Cancer
GlobeNewswire
·
July 25, 2025
MINNEAPOLIS, July 25, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced the Company will hold a conference call and webcast on Monday, July …
Recognify Life Sciences Provides Update on Phase 2b Trial of Inidascamine in Patients with Cognitive Impairment Associated with Schizophrenia
GlobeNewswire
·
July 25, 2025
Initial results demonstrate numerical improvement of cognitive and functional measures with inidascamine across both active treatment arms compared to placebo, but did not meet statistical significance on the primary endpoint Inidascamine continues to …
NurExone Biologic Finalist in Falling Walls Venture 2025 Global Platform Showcasing The World’s Most Promising Science-Based Start-Ups
GlobeNewswire
·
July 25, 2025
TORONTO and HAIFA, Israel, July 25, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”) is pleased to announce that the Falling Walls Foundation has named the Company a finalist in Falling …
Silvercrest Asset Management (SAMG) to Announce Second Quarter 2025 Results and Host Investor Conference Call
GlobeNewswire
·
July 25, 2025
NEW YORK, July 25, 2025 (GLOBE NEWSWIRE) -- Silvercrest Asset Management Group Inc. (NASDAQ: SAMG) announced today it will host a teleconference at 8:30 am Eastern Time on August 1, 2025, to discuss the company’s financial results for the second quarter …
Treatment.com AI Announces Non-Brokered Private Placement of up to C$3 million of Special Warrants and Units
GlobeNewswire
·
July 25, 2025
Vancouver, British Columbia, July 25, 2025 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (the “Company” or “Treatment”) (CSE: TRUE; OTC: TREIF; 939: FRA) is pleased to announce that due to strong inbound interest from new and existing investors, it is …
RBGLY INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Reckitt Benckiser Group PLC Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
GlobeNewswire
·
July 25, 2025
NEW YORK, July 25, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz …
SRPT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sarepta Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
GlobeNewswire
·
July 25, 2025
NEW YORK, July 25, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz …
LAZR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Luminar Technologies, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
GlobeNewswire
·
July 25, 2025
NEW YORK, July 25, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz …
REPL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Replimune Group, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
GlobeNewswire
·
July 25, 2025
NEW YORK, July 25, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz …
The J.M. Smucker Company (SJM) Faces Investor Scrutiny After Announcing The Second Hostess-Related Impairments In About 3 Months – Hagens Berman
GlobeNewswire
·
July 25, 2025
SAN FRANCISCO, July 25, 2025 (GLOBE NEWSWIRE) -- On June 10, 2025 investors in The J.M. Smucker Company (NYSE: SJM) saw the price of their shares decline over 15% after the company announced disappointing Q4 2025 financial results. This announcement has …
Movement Room Hits 250 Google 5-Star Reviews, Cementing Position as Best Physiotherapy Clinic in Vancouver
GlobeNewswire
·
July 25, 2025
Vancouver, BC, July 25, 2025 (GLOBE NEWSWIRE) -- Movement Room – Physiotherapy East Vancouver proudly announces its latest achievement of 250 5-star reviews on Google, further solidifying its reputation as the best physiotherapy clinic in Vancouver. …
Hubbell Incorporated Reports Regular Quarterly Dividend
GlobeNewswire
·
July 25, 2025
Shelton, CT, July 25, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of Hubbell Incorporated (NYSE:HUBB) today declared a regular quarterly dividend of $1.32 per share on the Company’s common stock. The dividend will be paid September 15, 2025 to …
CAPR Class Action Alert: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Capricor Therapeutics, Inc. Securities Class Action
GlobeNewswire
·
July 25, 2025
SAN DIEGO, July 25, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired Capricor Therapeutics, Inc. (NASDAQ: CAPR) securities between October 9, 2024 and July 10 …
RXST Investor Notice: Robbins LLP Reminds Stockholders of the Class Action Against RxSight, Inc.
GlobeNewswire
·
July 25, 2025
SAN DIEGO, July 25, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired RxSight, Inc. (NASDAQ: RXST) securities between November 7, 2024 and July 8, 2025. …
BHVN Class Action Alert: Robbins LLP Reminds Biohaven Ltd. Stockholders of the Lead Plaintiff Deadline in the Class Action Against BHVN
GlobeNewswire
·
July 25, 2025
SAN DIEGO, July 25, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired Biohaven Ltd. (NYSE: BHVN) securities between March 24, 2023 and May 14, 2025. Biohaven …
Best Kratom? Super Speciosa Relaunches Enhanced Watermelon Kratom Tincture in 2025
GlobeNewswire
·
July 25, 2025
Los Angeles, July 25, 2025 (GLOBE NEWSWIRE) -- As kratom interest surges across the U.S. in 2025, Super Speciosa has relaunched its Watermelon Kratom Tincture with an enhanced, lab-verified formula, marking a key update in one of its most popular delivery …